Analystreport

Kala Pharmctls (NASDAQ: KALA) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $46.00 price target on the stock.

Kala Pharmaceuticals, Inc.  (KALA) 
Last kala pharmaceuticals, inc. earnings: 2/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.kalarx.com